In this episode of The Deep Dive, supported by RevGenetics, Les and Amy explore a fascinating and terrifying breakthrough in oncology research: aggressive brain cancer cells are adapting to chemotherapy by literally shape-shifting. Likening this survival tactic to a video game enemy evolving during a pause menu, the team unpacks how fast-moving glioblastoma cells respond to standard chemo. Instead of dying, these resilient cells enter a "zombie" state—halting their normal division but actively emitting harmful, toxic substances into their surroundings.

This discovery completely challenges the traditional understanding of chemotherapy's effects, shedding new light on cancer cell behavior post-treatment. Join us as we unpack how these dynamic survival tactics, cellular stress, and unexpected resilience are redefining the future of cancer therapy and cellular science.

Supported by RevGenetics – Science-Based Supplements For Healthy Aging
👉 Explore Longevity Products

Referenced Study:
🔗 Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide

Hashtags:
#Glioblastoma #CancerResearch #Chemotherapy #ZombieCells #RevGenetics #BrainCancer #CellularPlasticity #OncologyBreakthrough #DeepDivePodcast #Temozolomide #CancerCellResilience #MedicalScience #ShapeShiftingCells #CellularStress #CancerSurvivalTactics #SciencePodcast #HealthInnovation #CancerAdaptation #RevGeneticsSupport

Podden och tillhörande omslagsbild på den här sidan tillhör RevGenetics. Innehållet i podden är skapat av RevGenetics och inte av, eller tillsammans med, Poddtoppen.